Table of Content

1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Overview
1.1 Product Overview and Scope of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)
1.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Segment by Type
1.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Live Vaccine
1.2.3 Inactivated Vaccine
1.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Segment by Application
1.3.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Comparison by Application: (2021-2027)
1.3.2 Government Tender
1.3.3 Marketing
1.4 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Estimates and Forecasts
1.4.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue 2016-2027
1.4.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales 2016-2027
1.4.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Region: 2016 Versus 2021 Versus 2027

2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Competition by Manufacturers
2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Manufacturers (2016-2021)
2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Sites, Area Served, Product Type
2.5 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Competitive Situation and Trends
2.5.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Players Market Share by Revenue
2.5.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Retrospective Market Scenario by Region
3.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures by Country
3.3.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country
3.3.2 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures by Country
3.4.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country
3.4.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures by Region
3.5.1 Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region
3.5.2 Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures by Country
3.6.1 Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country
3.6.2 Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures by Country
3.7.1 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country
3.7.2 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Historic Market Analysis by Type
4.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2016-2021)
4.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Type (2016-2021)
4.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Type (2016-2021)

5 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Historic Market Analysis by Application
5.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2016-2021)
5.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Application (2016-2021)
5.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Application (2016-2021)

6 Key Companies Profiled
6.1 CNADC
6.1.1 CNADC Corporation Information
6.1.2 CNADC Description and Business Overview
6.1.3 CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.1.4 CNADC Product Portfolio
6.1.5 CNADC Recent Developments/Updates
6.2 Boehringer-Ingelheim
6.2.1 Boehringer-Ingelheim Corporation Information
6.2.2 Boehringer-Ingelheim Description and Business Overview
6.2.3 Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Boehringer-Ingelheim Product Portfolio
6.2.5 Boehringer-Ingelheim Recent Developments/Updates
6.3 MSD Animal Health
6.3.1 MSD Animal Health Corporation Information
6.3.2 MSD Animal Health Description and Business Overview
6.3.3 MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.3.4 MSD Animal Health Product Portfolio
6.3.5 MSD Animal Health Recent Developments/Updates
6.4 Sinopharm
6.4.1 Sinopharm Corporation Information
6.4.2 Sinopharm Description and Business Overview
6.4.3 Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sinopharm Product Portfolio
6.4.5 Sinopharm Recent Developments/Updates
6.5 Ceva
6.5.1 Ceva Corporation Information
6.5.2 Ceva Description and Business Overview
6.5.3 Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Ceva Product Portfolio
6.5.5 Ceva Recent Developments/Updates
6.6 Chengdu Tianbang Biological Products Co., Ltd.
6.6.1 Chengdu Tianbang Biological Products Co., Ltd. Corporation Information
6.6.2 Chengdu Tianbang Biological Products Co., Ltd. Description and Business Overview
6.6.3 Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Chengdu Tianbang Biological Products Co., Ltd. Product Portfolio
6.6.5 Chengdu Tianbang Biological Products Co., Ltd. Recent Developments/Updates
6.7 Tianjin Ruipu Biological Technology Co., Ltd.
6.6.1 Tianjin Ruipu Biological Technology Co., Ltd. Corporation Information
6.6.2 Tianjin Ruipu Biological Technology Co., Ltd. Description and Business Overview
6.6.3 Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Tianjin Ruipu Biological Technology Co., Ltd. Product Portfolio
6.7.5 Tianjin Ruipu Biological Technology Co., Ltd. Recent Developments/Updates
6.8 Qilu Animal Health
6.8.1 Qilu Animal Health Corporation Information
6.8.2 Qilu Animal Health Description and Business Overview
6.8.3 Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Qilu Animal Health Product Portfolio
6.8.5 Qilu Animal Health Recent Developments/Updates
6.9 Guangdong Wens Dahuanong Biotechnology Co., Ltd.
6.9.1 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Corporation Information
6.9.2 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Description and Business Overview
6.9.3 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Product Portfolio
6.9.5 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Recent Developments/Updates
6.10 CAVAC
6.10.1 CAVAC Corporation Information
6.10.2 CAVAC Description and Business Overview
6.10.3 CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.10.4 CAVAC Product Portfolio
6.10.5 CAVAC Recent Developments/Updates
6.11 Komipharm
6.11.1 Komipharm Corporation Information
6.11.2 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
6.11.3 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Komipharm Product Portfolio
6.11.5 Komipharm Recent Developments/Updates
6.12 Agrovet
6.12.1 Agrovet Corporation Information
6.12.2 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
6.12.3 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Agrovet Product Portfolio
6.12.5 Agrovet Recent Developments/Updates
6.13 Bioveta
6.13.1 Bioveta Corporation Information
6.13.2 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
6.13.3 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Bioveta Product Portfolio
6.13.5 Bioveta Recent Developments/Updates
6.14 Jinyu Bio-Technology
6.14.1 Jinyu Bio-Technology Corporation Information
6.14.2 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
6.14.3 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Jinyu Bio-Technology Product Portfolio
6.14.5 Jinyu Bio-Technology Recent Developments/Updates
6.15 Phibro Animal Health
6.15.1 Phibro Animal Health Corporation Information
6.15.2 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
6.15.3 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Phibro Animal Health Product Portfolio
6.15.5 Phibro Animal Health Recent Developments/Updates
6.16 Tiankang
6.16.1 Tiankang Corporation Information
6.16.2 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
6.16.3 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Tiankang Product Portfolio
6.16.5 Tiankang Recent Developments/Updates
6.17 Zoetis
6.17.1 Zoetis Corporation Information
6.17.2 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
6.17.3 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Zoetis Product Portfolio
6.17.5 Zoetis Recent Developments/Updates
6.18 Guangdong Yongshun Biological Pharmaceutical Co Ltd
6.18.1 Guangdong Yongshun Biological Pharmaceutical Co Ltd Corporation Information
6.18.2 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
6.18.3 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Guangdong Yongshun Biological Pharmaceutical Co Ltd Product Portfolio
6.18.5 Guangdong Yongshun Biological Pharmaceutical Co Ltd Recent Developments/Updates
6.19 Plec Bioengineering Co., Ltd.
6.19.1 Plec Bioengineering Co., Ltd. Corporation Information
6.19.2 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
6.19.3 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Plec Bioengineering Co., Ltd. Product Portfolio
6.19.5 Plec Bioengineering Co., Ltd. Recent Developments/Updates

7 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Cost Analysis
7.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)
7.4 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Distributors List
8.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Customers

9 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Dynamics
9.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Trends
9.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Growth Drivers
9.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Challenges
9.4 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Restraints

10 Global Market Forecast
10.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Type (2022-2027)
10.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Application (2022-2027)
10.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Covered in This Study
Table 5. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Share by Manufacturers (2016-2021)
Table 7. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Sites and Area Served
Table 11. Manufacturers Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Type
Table 12. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2016-2021) & (K Units)
Table 16. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Region (2016-2021)
Table 17. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2016-2021) & (K Units)
Table 19. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country (2016-2021)
Table 20. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country (2016-2021)
Table 22. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2016-2021) & (K Units)
Table 23. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country (2016-2021)
Table 24. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Region (2016-2021)
Table 30. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country (2016-2021)
Table 32. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country (2016-2021)
Table 38. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) by Type (2016-2021)
Table 39. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2016-2021)
Table 40. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (Million US$) by Type (2016-2021)
Table 41. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Share by Type (2016-2021)
Table 42. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price (US$/Unit) by Type (2016-2021)
Table 43. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) by Application (2016-2021)
Table 44. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2016-2021)
Table 45. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (Million US$) by Application (2016-2021)
Table 46. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Share by Application (2016-2021)
Table 47. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price (US$/Unit) by Application (2016-2021)
Table 48. CNADC Corporation Information
Table 49. CNADC Description and Business Overview
Table 50. CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 52. CNADC Recent Developments/Updates
Table 53. Boehringer-Ingelheim Corporation Information
Table 54. Boehringer-Ingelheim Description and Business Overview
Table 55. Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 57. Boehringer-Ingelheim Recent Developments/Updates
Table 58. MSD Animal Health Corporation Information
Table 59. MSD Animal Health Description and Business Overview
Table 60. MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 62. MSD Animal Health Recent Developments/Updates
Table 63. Sinopharm Corporation Information
Table 64. Sinopharm Description and Business Overview
Table 65. Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 67. Sinopharm Recent Developments/Updates
Table 68. Ceva Corporation Information
Table 69. Ceva Description and Business Overview
Table 70. Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 72. Ceva Recent Developments/Updates
Table 73. Chengdu Tianbang Biological Products Co., Ltd. Corporation Information
Table 74. Chengdu Tianbang Biological Products Co., Ltd. Description and Business Overview
Table 75. Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 77. Chengdu Tianbang Biological Products Co., Ltd. Recent Developments/Updates
Table 78. Tianjin Ruipu Biological Technology Co., Ltd. Corporation Information
Table 79. Tianjin Ruipu Biological Technology Co., Ltd. Description and Business Overview
Table 80. Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 82. Tianjin Ruipu Biological Technology Co., Ltd. Recent Developments/Updates
Table 83. Qilu Animal Health Corporation Information
Table 84. Qilu Animal Health Description and Business Overview
Table 85. Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 87. Qilu Animal Health Recent Developments/Updates
Table 88. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Corporation Information
Table 89. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Description and Business Overview
Table 90. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 92. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Recent Developments/Updates
Table 93. CAVAC Corporation Information
Table 94. CAVAC Description and Business Overview
Table 95. CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 97. CAVAC Recent Developments/Updates
Table 98. Komipharm Corporation Information
Table 99. Komipharm Description and Business Overview
Table 100. Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 102. Komipharm Recent Developments/Updates
Table 103. Agrovet Corporation Information
Table 104. Agrovet Description and Business Overview
Table 105. Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 107. Agrovet Recent Developments/Updates
Table 108. Bioveta Corporation Information
Table 109. Bioveta Description and Business Overview
Table 110. Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 112. Bioveta Recent Developments/Updates
Table 113. Jinyu Bio-Technology Corporation Information
Table 114. Jinyu Bio-Technology Description and Business Overview
Table 115. Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 117. Jinyu Bio-Technology Recent Developments/Updates
Table 118. Phibro Animal Health Corporation Information
Table 119. Phibro Animal Health Description and Business Overview
Table 120. Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 122. Phibro Animal Health Recent Developments/Updates
Table 123. Tiankang Corporation Information
Table 124. Tiankang Description and Business Overview
Table 125. Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 127. Tiankang Recent Developments/Updates
Table 128. Zoetis Corporation Information
Table 129. Zoetis Description and Business Overview
Table 130. Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 132. Zoetis Recent Developments/Updates
Table 133. Guangdong Yongshun Biological Pharmaceutical Co Ltd Corporation Information
Table 134. Guangdong Yongshun Biological Pharmaceutical Co Ltd Description and Business Overview
Table 135. Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 136. Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 137. Guangdong Yongshun Biological Pharmaceutical Co Ltd Recent Developments/Updates
Table 138. Plec Bioengineering Co., Ltd. Corporation Information
Table 139. Plec Bioengineering Co., Ltd. Description and Business Overview
Table 140. Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 141. Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 142. Plec Bioengineering Co., Ltd. Recent Developments/Updates
Table 143. Production Base and Market Concentration Rate of Raw Material
Table 144. Key Suppliers of Raw Materials
Table 145. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Distributors List
Table 146. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Customers List
Table 147. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Trends
Table 148. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Growth Drivers
Table 149. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Restraints
Table 150. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Type (2022-2027) & (K Units)
Table 151. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share Forecast by Type (2022-2027)
Table 152. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 153. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share Forecast by Type (2022-2027)
Table 154. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Application (2022-2027) & (K Units)
Table 155. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share Forecast by Application (2022-2027)
Table 156. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 157. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share Forecast by Application (2022-2027)
Table 158. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Forecast by Region (2022-2027) & (K Units)
Table 159. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share Forecast by Region (2022-2027)
Table 160. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 161. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share Forecast by Region (2022-2027)
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)
Figure 2. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share by Type in 2020 & 2027
Figure 3. Live Vaccine Product Picture
Figure 4. Inactivated Vaccine Product Picture
Figure 5. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share by Application in 2020 & 2027
Figure 6. Government Tender
Figure 7. Marketing
Figure 8. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size 2016-2027 (US$ Million)
Figure 10. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales 2016-2027 (K Units)
Figure 11. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Share by Manufacturers in 2020
Figure 13. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Players: Market Share by Revenue in 2020
Figure 15. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Region (2016-2021)
Figure 17. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Region in 2020
Figure 18. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Region (2016-2021)
Figure 19. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Region in 2020
Figure 20. U.S. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Type (2016-2021)
Figure 45. Sales Market Share of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Application (2016-2021)
Figure 46. Sales Market Share of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Application in 2020
Figure 47. Revenue Share of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Application (2016-2021)
Figure 48. Revenue Share of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Application in 2020
Figure 49. Manufacturing Cost Structure of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)
Figure 50. Manufacturing Process Analysis of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)
Figure 51. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed